AbbVie expands board to 13, appoints UC San Diego's John Carethers

AbbVie has expanded its board of directors to 13 members and appointed Dr. John M. Carethers as a director, according to an 8-K filed Oct. 15.

The drugmaker's board took the action on Oct. 14, adding one seat to its previous 12. Carethers joins as a Class II director.

Carethers is vice chancellor for health sciences at the University of California San Diego, according to the filing. He previously served as a director of Avantor, Inc.

Committee and independence

Carethers has been appointed to AbbVie's Public Policy and Sustainability Committee. The board determined that he is independent under New York Stock Exchange standards and AbbVie's own governance guidelines.

He will be paid under AbbVie's standard independent director compensation, which the company previously disclosed in a quarterly report for the period ended March 31, 2025.

Sources

1. AbbVie Inc. Form 8-K, filed Oct. 15, 2026, accession 0001104659-26-116227

This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.

Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.